From the editors: BioPharma Reporter is tailoring the news to your needs

By Jane Byrne contact

- Last updated on GMT

© GettyImages/Klaus Vedfelt
© GettyImages/Klaus Vedfelt

Related tags: podcasts, webinars, subscribers

BioPharma Reporter is enhancing its digital service, looking to improve the readers' experience.

From today, we are asking site users to register with us​ to continue to interact with our news content, as we, like many news organizations globally, implement what is known as ‘metered’ access.

It is part of our ongoing strategy to develop a deeper relationship with our readers.

For now, we are only metering news content. Other pages such as resources, podcasts, promotional features listing pages and the homepage are still accessible without limitations.

To access more than two stories over 30 days, readers must register

Newsletter subscribers will continue to receive newsletters as normal and they, together with those visiting the site via search engines or social media, can read two full stories over 30 days​ before being asked to register.

Once you have created an account and signed in, our system will remember your device, meaning you are not required to sign in every time you visit using the same device. If this is not happening, please check your browser settings and ensure you are allowing cookies on our website.

It’s totally free

The registration process is simple, and no payment is required. We are just asking for some basic information such as your email address and industry specific demographics.

Our FAQ page​ is designed to answer all potential questions on the registration process. 

Why register?

Knowing more about you will help us tailor content to your needs.

By registering, in future, BioPharma-Reporter will be able to personalize content you receive​ via email newsletters, only inform you about webinars, events and downloadable resources that you really care about and keep you up to date on the latest developments in your niche areas of interest.

With these changes, we hope to further improve the on-site experience of all readers. We look forward to providing you with even more must-read content so you can keep track of the global biopharma industry.

Related topics: Markets & Regulations